Know Cancer

or
forgot password

Improving Patient-Provider Communication For Colorectal Cancer Screening


N/A
50 Years
74 Years
Not Enrolling
Both
Colorectal Cancer

Thank you

Trial Information

Improving Patient-Provider Communication For Colorectal Cancer Screening


In the United States, colorectal cancer is the third most common cancer and the second
leading cause of cancer mortality with over 56,000 deaths in 2004). Early detection through
screening decreases the mortality associated with the disease. However, adherence with
current screening recommendations is low. A survey of the general population indicates that
only 53.1% of Americans, age 50 years and older for whom colorectal cancer screening is
recommended, are up-to-date with this preventive service. While colorectal cancer screening
rates with the VA Healthcare System (VHA) are better than in the general population (75% in
FY 2005), they are lower than performance rates for other types of cancer screening (e.g.,
mammography) in VHA. Further, numerous VA medical centers report colorectal cancer screening
rates below the level considered satisfactory. Of 138 VA medical centers, 25% reported
colorectal cancer screening rates as


Inclusion Criteria:



Provider Eligibility. Primary care providers (MD, CRNP, or PA) at the study sites who see
patients in the primary care setting at least 1 day per week and had no involvement in the
design of the study are eligible for enrollment in the study.

Patient Eligibility. Primary care patients who are not "up-to-date" with colorectal cancer
screening are the targeted population for study enrollment. Up-to-date with colorectal
cancer screening is defined as having completed one of the following: (1) fecal occult
blood testing within the past year; (2) sigmoidoscopy within the past 5 years; (3)
colonoscopy within the past 10 years; or (4) barium enema within the past 5 years. Other
patient eligibility criteria are: (1) PCP enrolled in the study; (2) clinic visit
scheduled with the enrolled PCP during the recruitment period; (3) age 50-74 years; (4)
English speaking; (5) no prior history of colorectal cancer or adenomatous polyps; and (6)
no prior history of inflammatory bowel disease.

Exclusion Criteria:

Patients who are deemed clinically not appropriate for colorectal cancer screening due to
severe comorbidity and/or limited life expectancy as determined by the patient's primary
care provider will be excluded from the study.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Prevention

Outcome Measure:

(1) completion of colorectal cancer screening tests; (2) quality of communication; and (3) communication content

Safety Issue:

No

Principal Investigator

Bruce S. Ling, MD MPH

Investigator Role:

Principal Investigator

Investigator Affiliation:

Center for Health Equity Research and Promotion

Authority:

United States: Federal Government

Study ID:

IIR 03-252

NCT ID:

NCT00324753

Start Date:

April 2007

Completion Date:

January 2009

Related Keywords:

  • Colorectal Cancer
  • cancer
  • screening
  • communication
  • prevention
  • Colorectal Neoplasms

Name

Location

Jesse Brown VAMC (WestSide Division) Chicago, Illinois  60612
Center for Health Equity Research and Promotion Pittsburgh, Pennsylvania  15206
Houston VA Medical Center Houston, Texas  77030